PortfoliosLab logoPortfoliosLab logo
MEDI vs. IDNA
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

MEDI vs. IDNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Harbor Health Care ETF (MEDI) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MEDI achieves a -4.02% return, which is significantly lower than IDNA's 10.31% return.


MEDI

1D
1.06%
1M
-0.93%
YTD
-4.02%
6M
-4.83%
1Y
18.27%
3Y*
12.46%
5Y*
10Y*

IDNA

1D
0.73%
1M
-2.56%
YTD
10.31%
6M
8.52%
1Y
40.87%
3Y*
6.74%
5Y*
-8.42%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

MEDI vs. IDNA - Yearly Performance Comparison


2026 (YTD)2025202420232022
MEDI
Harbor Health Care ETF
-4.02%27.11%0.58%24.87%2.60%
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
10.31%17.26%-0.72%-7.63%-9.78%

Correlation

The correlation between MEDI and IDNA is 0.76, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.76

Correlation (3Y)
Calculated over the trailing 3-year period

0.69

Correlation (All Time)
Calculated using the full available price history since Nov 18, 2022

0.69

The correlation between MEDI and IDNA has been stable across timeframes, ranging from 0.69 to 0.76 - a consistent structural relationship.

MEDI vs. IDNA - Sectors Allocation Comparison


Sectors
MEDI
IDNA

Healthcare

100.0%
97.8%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Industrials

-

0.4%

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

MEDI
100.0%
IDNA
97.8%

Basic Materials

MEDI

-

IDNA

-

Communication Services

MEDI

-

IDNA

-

Consumer Cyclical

MEDI

-

IDNA

-

Consumer Defensive

MEDI

-

IDNA

-

Energy

MEDI

-

IDNA

-

Financial Services

MEDI

-

IDNA

-

Industrials

MEDI

-

IDNA
0.4%

Real Estate

MEDI

-

IDNA

-

Technology

MEDI

-

IDNA

-

Utilities

MEDI

-

IDNA

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MEDI vs. IDNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MEDI
MEDI Risk / Return Rank: 2626
Overall Rank
MEDI Sharpe Ratio Rank: 2626
Sharpe Ratio Rank
MEDI Sortino Ratio Rank: 2727
Sortino Ratio Rank
MEDI Omega Ratio Rank: 2424
Omega Ratio Rank
MEDI Calmar Ratio Rank: 2525
Calmar Ratio Rank
MEDI Martin Ratio Rank: 2626
Martin Ratio Rank

IDNA
IDNA Risk / Return Rank: 5555
Overall Rank
IDNA Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
IDNA Sortino Ratio Rank: 4949
Sortino Ratio Rank
IDNA Omega Ratio Rank: 4242
Omega Ratio Rank
IDNA Calmar Ratio Rank: 7676
Calmar Ratio Rank
IDNA Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MEDI vs. IDNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Harbor Health Care ETF (MEDI) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MEDIIDNADifference

Sharpe ratio

Return per unit of total volatility

0.93

1.68

-0.75

Sortino ratio

Return per unit of downside risk

1.46

2.44

-0.98

Omega ratio

Gain probability vs. loss probability

1.17

1.27

-0.11

Calmar ratio

Return relative to maximum drawdown

1.20

3.85

-2.65

Martin ratio

Return relative to average drawdown

3.59

10.98

-7.39

MEDI vs. IDNA - Sharpe Ratio Comparison

The current MEDI Sharpe Ratio is 0.93, which is lower than the IDNA Sharpe Ratio of 1.68. The chart below compares the historical Sharpe Ratios of MEDI and IDNA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


MEDIIDNADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.93

1.68

-0.75

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.30

Sharpe Ratio (All Time)

Calculated using the full available price history

0.74

0.10

+0.64

Drawdowns

MEDI vs. IDNA - Drawdown Comparison

The maximum MEDI drawdown since its inception was -19.24%, smaller than the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for MEDI and IDNA.


Loading charts...

Drawdown Indicators


MEDIIDNADifference

Max Drawdown

Largest peak-to-trough decline

-19.24%

-68.26%

+49.02%

Max Drawdown (1Y)

Largest decline over 1 year

-15.34%

-10.66%

-4.68%

Max Drawdown (3Y)

Largest decline over 3 years

-19.24%

-29.73%

+10.49%

Max Drawdown (5Y)

Largest decline over 5 years

-68.26%

Current Drawdown

Current decline from peak

-8.01%

-45.61%

+37.60%

Average Drawdown

Average peak-to-trough decline

-4.28%

-36.24%

+31.96%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.10%

3.73%

+1.37%

Volatility

MEDI vs. IDNA - Volatility Comparison

The current volatility for Harbor Health Care ETF (MEDI) is 6.02%, while iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) has a volatility of 7.18%. This indicates that MEDI experiences smaller price fluctuations and is considered to be less risky than IDNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MEDIIDNADifference

Volatility (1M)

Calculated over the trailing 1-month period

6.02%

7.18%

-1.16%

Volatility (6M)

Calculated over the trailing 6-month period

15.42%

17.98%

-2.56%

Volatility (1Y)

Calculated over the trailing 1-year period

19.82%

24.48%

-4.66%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.63%

28.42%

-9.79%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.63%

29.53%

-10.90%

MEDI vs. IDNA - Expense Ratio Comparison

MEDI has a 0.80% expense ratio, which is higher than IDNA's 0.47% expense ratio.


Dividends

MEDI vs. IDNA - Dividend Comparison

MEDI's dividend yield for the trailing twelve months is around 0.29%, less than IDNA's 1.07% yield.


PositionTTM2025202420232022202120202019
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
1.07%1.18%0.98%1.04%0.54%0.70%0.26%0.80%
MEDI
Harbor Health Care ETF
0.29%0.28%0.54%1.86%0.00%0.00%0.00%0.00%

Frequently Asked Questions


MEDI and IDNA have a correlation of 0.76, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IDNA has higher volatility (7.18%) compared to MEDI (6.02%). In terms of maximum drawdown, MEDI dropped -19.24% vs IDNA's -68.26%.

On 3-year performance, MEDI leads with 12.46% vs 6.74% for IDNA. On fees, IDNA is cheaper at 0.47% per year. On volatility, MEDI has been the lower-risk option at 6.02%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 3-year period, MEDI has performed better with a 12.46% return vs 6.74%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IDNA is cheaper with a 0.47% expense ratio, compared with 0.80% for MEDI.

IDNA has the higher dividend yield at 1.07%, compared with 0.29% for MEDI.

They also come from different issuers: Harbor and iShares. Their fees differ too: 0.80% for MEDI and 0.47% for IDNA.

IDNA currently has the higher Sharpe Ratio (1.68 vs 0.93), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MEDI and IDNA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer